Twin to twin transfusion syndrome (TTTS) is a rare complication of identical twin pregnancies. It happens when twins share a single placenta and the blood vessels inside that placenta connect in a way that lets blood flow unevenly between them. One twin gets too much blood. The other gets too little. Without treatment, TTTS can become dangerous for both babies.
It only occurs in identical twins who share one placenta. That detail matters, because it explains why the condition develops at all.
What Is Twin To Twin Transfusion Syndrome?
TTTS is an imbalance of blood flow between two fetuses who share one placenta. The shared placenta contains blood vessel connections, called anastomoses, that link the twins’ circulatory systems. In most identical twin pregnancies with one placenta, these connections are balanced and cause no problem. In TTTS, the connections are unbalanced, so one twin steadily pumps blood toward the other.
The twin who loses blood is called the donor. The twin who receives the extra blood is called the recipient. Both are at risk, but for different reasons.
The donor twin can become anemic and dehydrated. It may produce less urine, which means less amniotic fluid around it. The recipient twin gets overloaded with blood and fluid. Its heart has to work harder, and it may produce too much urine, leading to extra amniotic fluid.
This is why TTTS is sometimes described as a plumbing problem, not a genetic one. The twins are genetically identical. The problem is the shared blood supply.
How Common Is TTTS and Who Is at Risk?
TTTS affects roughly 10 to 15 percent of identical twin pregnancies where the babies share one placenta. That shared placenta, called a monochorionic placenta, is the key risk factor. Without it, TTTS cannot occur.
About two-thirds of identical twins share one placenta. The rest have two separate placentas and are not at risk for TTTS. Fraternal twins always have two placentas, so they never develop it.
The main risk factor is simply having a monochorionic twin pregnancy. Beyond that, the evidence on other risk factors is less clear. Some research suggests certain placental vessel patterns raise the risk, but this is not something a parent can control or predict.
TTTS is not caused by anything the mother does or does not do during pregnancy. It is not linked to diet, activity, or stress. It results from how the shared placenta formed early in pregnancy.
What Are the Symptoms and Warning Signs?
TTTS usually causes no symptoms in the mother. This is the part that surprises many people. The mother often feels fine while the condition is developing.
When symptoms do appear, they tend to be related to extra amniotic fluid, a condition called polyhydramnios. A woman might notice rapid weight gain, a uterus that measures larger than expected for the stage of pregnancy, or unusual abdominal tightness or pressure. Some women report shortness of breath as the uterus presses upward.
These signs are not specific to TTTS. They can happen in many pregnancies for other reasons. That is why TTTS is usually found through ultrasound monitoring, not through symptoms.
Identical twins who share a placenta are typically monitored with regular ultrasounds, often every two weeks, starting in the second trimester. This schedule is designed to catch TTTS early, before symptoms would be noticeable.
How Is TTTS Diagnosed?
Diagnosis is made by ultrasound. The two key findings are a large difference in amniotic fluid between the twins and, in many cases, a visible difference in bladder size.
Specifically, doctors look for one twin with too much amniotic fluid and the other with too little. The donor twin often has a small or empty bladder because it is not producing much urine. The recipient twin may have a large, full bladder.
Doctors also check the blood flow in the twins’ umbilical cords and look at the recipient twin’s heart. These checks help determine how serious the condition is. TTTS is often staged from one to five, with higher stages indicating more severe disease.
Early diagnosis matters. Outcomes are generally better when TTTS is caught and treated before it progresses to advanced stages.
How Is TTTS Treated?
The main treatment is a procedure called fetoscopic laser surgery. A surgeon uses a thin scope inserted into the uterus to find and seal the blood vessel connections between the twins. This stops the uneven blood flow at its source.
Laser surgery is generally considered the preferred treatment for moderate to severe TTTS, particularly before a certain point in pregnancy. Research has found it improves survival compared to other approaches in many cases, though outcomes vary based on how advanced the condition is when treated.
Other options exist but are used less often or in specific situations. These include draining extra amniotic fluid with a needle, which can relieve pressure but does not fix the underlying vessel connections. In very early or very advanced cases, doctors may recommend different approaches based on the specific circumstances.
Some mild cases are monitored closely without immediate surgery, because a small number of cases stabilize or improve on their own. This decision is made case by case, based on staging and how the babies are doing.
Treatment decisions in TTTS are complex and depend on many factors, including gestational age, disease stage, and the health of each twin. They are made by specialized maternal-fetal medicine teams.
What Are the Risks and Outcomes?
TTTS is a serious condition. Without treatment, it can lead to the loss of one or both twins. The donor twin is at risk from anemia and poor growth. The recipient twin is at risk from heart strain and fluid overload.
With treatment, outcomes have improved substantially over recent decades. Survival rates vary widely depending on how early the condition is caught, how severe it is, and the experience of the treatment center. In general, laser surgery gives both twins a reasonable chance of survival, though complications can still occur.
Even after successful treatment, TTTS pregnancies carry higher risks. These can include preterm birth, neurological problems in one or both twins, and heart issues in the recipient twin. Some of these problems may not be apparent until after birth or later in childhood.
This is why TTTS pregnancies are followed closely by specialists, and why babies born after TTTS often receive additional monitoring.
What Should Parents Expect?
A TTTS diagnosis is frightening. It comes with a lot of uncertainty and a lot of medical decisions in a short amount of time. Knowing what the condition is and how it is treated can help parents ask better questions and understand what their care team is recommending.
The most important thing is early detection. Regular ultrasound monitoring for monochorionic twins is what makes early treatment possible. If you are pregnant with identical twins who share a placenta, ask your doctor about your monitoring schedule.
TTTS is rare, but it is not random. It follows a pattern that doctors understand and watch for. That understanding is what has changed outcomes for these pregnancies over the past several decades.
Frequently Asked Questions
Can TTTS happen in fraternal twins?
No. TTTS only occurs when twins share a single placenta, which happens only with identical twins. Fraternal twins always have two separate placentas and cannot develop TTTS.
Is TTTS preventable?
No. TTTS results from how the shared placenta forms early in pregnancy, and there is no known way to prevent it. The focus is on early detection through regular ultrasound monitoring.
Can TTTS resolve on its own?
In a small number of mild cases, the condition stabilizes without surgery. However, this is not common, and doctors monitor these cases very closely to decide if treatment becomes necessary.
Does TTTS affect both twins equally?
No. The donor twin loses blood and the recipient twin receives too much, so each faces different risks. Both twins need careful monitoring and, in many cases, treatment.
